-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Provoked vs Minimally Provoked vs Unprovoked VTE—Does it Matter?

Program: Education Program
Session: Ongoing Challenges in the Management of VTE
Hematology Disease Topics & Pathways:
Research, Clinical Practice (Health Services and Quality), Clinical Research, Therapies
Saturday, December 9, 2023, 2:00 PM-3:15 PM

Cecilia Becattini, MD

University of Perugia, Perugia, Italy

Disclosures: Becattini: Bayer HealthCare: Honoraria, Speakers Bureau; Bristol Myers Squibb: Honoraria; Daiichi Sankyo: Honoraria.

See more of: Ongoing Challenges in the Management of VTE
See more of: Education Program
Previous Presentation | Next Presentation >>